Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01107418
Show Display Options
Rank Status Study
1 Completed A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma
Condition: Malignant Melanoma
Intervention: Drug: RO5185426

Indicates status has not been verified in more than two years